Neuron death during development and in Alzheimer's disease (AD) is associated with aberrant regulation/induction of cell cycle proteins. However, the proximal events in this process are unknown. Cell cycle initiation requires dephosphorylation of cyclin-dependent kinases by cell division cycle 25A (Cdc25A). Here, we show that Cdc25A is essential for neuronal death in response to NGF deprivation or -amyloid (A) treatment and describe the mechanisms by which it is regulated in these paradigms. Cdc25A mRNA, protein and Cdc25A phosphatase activity were induced by NGF deprivation and A treatment. Enhanced Cdc25A expression was also observed in rat brains infused with A and in A-overexpressing APPswe-PS1dE9 mice. In cultured neurons Cdc25A inhibition by chemical inhibitors or shRNA prevented cell death and neurite degeneration caused by NGF deprivation or A. Additionally, Cdc25A inhibition diminished distal signaling events including Cdk-dependent elevation of phospho-pRb and subsequent caspase-3 activation. Mechanism studies revealed that Cdc25A induction by NGF deprivation and A is mediated by activation of Forkhead transcription factors that in turn suppress miR-21, a negative regulator of Cdc25A. Our studies thus identify Cdc25A as a required upstream element of the apoptotic cell cycle pathway that is required for neuron death in response to trophic factor deprivation and to A exposure and therefore as a potential target to suppress pathologic neuron death.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5149581PMC
http://dx.doi.org/10.1038/cddiscovery.2016.83DOI Listing

Publication Analysis

Top Keywords

ngf deprivation
20
neuron death
16
cell cycle
12
cdc25a
11
cdc25a phosphatase
8
induced ngf
8
deprivation -amyloid
8
death response
8
cdc25a inhibition
8
death
6

Similar Publications

This study aims to investigate the effect of Anmeidan on hippocampal neurons and synaptic microenvironments in sleep-deprived rats. Sixty SD rats were randomly divided into blank, model, Anmeidan, and melatonin groups, with 15 rats in one group. The study used the multi-platform method to prepare the sleep deprivation model.

View Article and Find Full Text PDF

Apoptosis is a fundamental process of all mammalian cells but exactly how it is regulated in different primary cells remains less explored. In most contexts, apoptosis is engaged to eliminate cells. However, postmitotic cells such as neurons must efficiently balance the need for developmental apoptosis versus the physiological needs for their long-term survival.

View Article and Find Full Text PDF
Article Synopsis
  • Therapeutic hypothermia (TH) is now a standard treatment to reduce brain damage in newborns with hypoxic-ischaemic encephalopathy (HIE), but many still face high rates of death and disabilities.
  • CHF6467 is a modified form of nerve growth factor (NGF) that does not cause pain and has shown protective effects on neurons in rodent models when used with hypothermia.
  • This study suggests that combining intranasal administration of CHF6467 with TH significantly reduces brain damage and improves motor and memory function in neonatal HIE, making it a promising treatment option.
View Article and Find Full Text PDF

The blood-brain barrier (BBB) strictly limits the entry of most exogenous therapeutic drugs into the brain, which brings great challenges to the drug treatment of refractory central diseases, including the treatment of ischemic stroke. Our previous studies have shown that specific mode electroacupuncture stimulation (SMES) can temporarily open the BBB, but with the mechanisms largely unknown. This study explored whether SMES opens the BBB in the infarcted border zone of rats during middle cerebral artery occlusion/reperfusion recovery, and whether this is related to p65 or vascular endothelial growth factor A (VEGFA) modulation of tight junction protein expression through in vivo and in vitro studies.

View Article and Find Full Text PDF
Article Synopsis
  • This study examines the role of microRNA-128-3p (miR-128-3p) in neuronal death and behavior changes in a rat model of cerebral palsy (CP), focusing on its interaction with Smurf2 and YY1.
  • Researchers established a hypoxic-ischemic (HI) CP model in neonatal rats and performed various tests to evaluate brain damage and neurobehavioral performance post-injury.
  • Results indicated that reducing miR-128-3p or increasing Smurf2 improved neurobehavior and reduced neuronal apoptosis, suggesting a potential therapeutic pathway involving miR-128-3p, Smurf2, and YY1 in hypoxic-ischemic brain injuries.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!